Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Argus Health
Farmers Insurance
Julphar
Colorcon
AstraZeneca
Chubb
Citi

Generated: October 18, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,038,988

« Back to Dashboard

Summary for Patent: 8,038,988
Title:Method of enhancing hair growth
Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I ##STR00001## wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, R.sub.1 and R.sub.2 are as defined in the specification. Such compositions are used in treating the skin or scalp of a human or non-human animal. Bimatoprost is preferred for this treatment.
Inventor(s): Woodward; David F. (Lake Forest, CA), VanDenburgh; Amanda M. (Huntington Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:11/943,714
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,038,988
Patent Claims: 1. A method of increasing one or more of: length, thickness, number, density, luster, sheen, brilliance, gloss, glow, shine and patina of eyelash hair in a human, comprising administering an effective amount of bimatoprost to an eyelid margin of a human.

2. The method of claim 1 wherein the effective amount of bimatoprost is administered in the form of a liquid composition containing about 0.03% bimatoprost by weight of the composition.

3. The method of claim 1 wherein bimatoprost is administered to an eyelid margin at least once a day.

4. The method of claim 1 further including a method of increasing one or more of: length, thickness, number, density, luster, sheen, brilliance, gloss, glow, shine and patina of eyebrow hair in a human, comprising administering an effective amount of bimatoprost to the eyebrow of the human.

5. The method of claim 4 wherein the effective amount of bimatoprost is administered in the form of a liquid composition containing about 0.03% by weight of the composition.

6. The method of claim 2 wherein the composition is a solution.

7. A method of increasing one or more of: length, thickness, number, density, luster, sheen, brilliance, gloss, glow, shine and patina, of hair on a human scalp, comprising administering an effective amount of bimatoprost to the human scalp.

8. The method of claim 7 wherein the effective amount of bimatoprost is administered in the form of a liquid composition containing about 0.001% to about 0.1% bimatoprost by weight of the composition.

9. The method of claim 8 wherein the effective amount of bimatoprost is administered in the form of a liquid composition containing about 0.03% bimatoprost by weight of the composition.

10. The method of claim 1 wherein the effective amount is administered in the form of a liquid composition containing about 0.001% to about 0.1% bimatoprost by weight of the composition.

11. The method of claim 1 wherein the human is suffering from eyelass loss.

12. The method of claim 7 wherein the human is suffering from hair loss.

13. The method of claim 12 wherein the hair loss is due to alopecia.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Mallinckrodt
Cipla
Colorcon
Federal Trade Commission
Johnson and Johnson
Fish and Richardson
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.